OncBioMune Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals, Inc. (OBMP) related to its merger with Avant Diagnostics, Inc. Under the terms of the agreement, OBMP will acquire all of the outstanding assets of Avant diagnostic in exchange for a number of shares of its Series D-1 Preferred Convertible Stock, with current shareholders of OBMP expected to own 45.5% of the common … Read more